Lv4
780 积分 2026-05-02 加入
Complement inhibitor therapy in thymoma-associated myasthenia gravis: a real-world experience
2小时前
待确认
Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort Study
2个月前
已完结
Eculizumab as rescue therapy in refractory anti-NXP2 dermatomyositis with digestive vasculitis and gastrointestinal perforation: report of two cases
2个月前
已完结
Safety and Effectiveness of Eculizumab in Patients With Refractory Ocular or Ocular‐Predominant Myasthenia Gravis: A Case Series
2个月前
已完结
Lymphocyte alterations and elevated complement signalling are key features of refractory myasthenia gravis
2个月前
已完结
Fatigue in patients with myasthenia gravis. A systematic review of the literature
2个月前
已完结
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial
2个月前
已完结
A new era in neurology
3个月前
已完结
Thrombotic Microangiopathy in the Setting of HIV Infection: A Case Report and Review of the Differential Diagnosis and Therapy
3个月前
已完结
皖公网安备34019202002308
